« Back to Record
Dodion, P., Rozencweig, M., & Nicaise, C. (1982). Phase I clinical study of 9-hydroxy-2N-methyl-ellipticinium acetate (NSC-264137) administered on a 5-day i.v. schedule. European journal of cancer & clinical oncology, 18(6), 519-522.
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/164998



